Bigcef-CV 625 Tablet
Marketer
BestoChem Formulations India Ltd
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Bigcef-CV 625 Tablet
Cefixime and Clavulanate Potassium 625mg tablets combat diverse bacterial infections by hindering microbial proliferation. This prescription medication should be taken precisely as directed. Administration with or without food is acceptable, but consistent timing optimizes effectiveness. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken promptly upon recollection. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration promote faster recovery. Your physician may order blood work and diagnostic tests to monitor treatment response.
Primary Ingredients of Bigcef-CV 625 Tablet
No information provided. Therefore, no rephrased text can be generated.
Uses of Bigcef-CV 625 Tablet
Managing bacterial infections
Major Benefits of Bigcef-CV 625 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bigcef-CV 625 Tablets can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Bigcef-CV 625 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Bigcef-CV 625 Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bigcef-CV 625 Tablets can be consumed with or without food, although consistent timing is recommended.
How Bigcef-CV 625 Tablet works:
Cefuroxime and Clavulanate potassium, combined as Bigcef-CV 625 Tablet, offer a dual-action approach to bacterial infections. Cefuroxime, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Clavulanate potassium, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise deactivate Cefuroxime. This synergistic effect broadens Cefuroxime's antibacterial spectrum and overcomes resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Bigcef-CV 625 Tablet consumption alongside alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefixime 625 mg tablets are typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefixime 625 mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingNOT RELEVANT
Inapplicable; Bigcef-CV 625 Tablets are prescribed solely for inpatients.
KidneyCONSULT YOUR DOCTOR
Data regarding Bigcef-CV 625 Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Bigcef-CV 625 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Bigcef-CV 625 Tablet :
Should you forget a Bigcef-CV 625 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bigcef-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |



